Meet the Team
Our mission-driven team is united by a shared sense of purpose and urgency: to bring a life-changing treatment to CMT1A patients as quickly as possible.

David Apple | Founder & CEO
Dedication.
- My 5 yr old son Ari has CMT1A.
- Ari had an earlier onset and has a severe presentation.
- CMT1A is progressive, and is reported to get worse during puberty.
- I have a sense of urgency and will not stop until a treatment is available for Ari.
Track-record.
- I'm a Mech Eng (Johns Hopkins) and an MBA (Imperial College London).
- I was the first go-to-market leader at Notion ($10B) and Typeform ($1B).
- I advise Sequoia Capital, First Round Capital, and Headline Ventures.
- 3x Founder. Teleconnect (acquired), Apple Sustainability (ran profitably 5 yrs).
Perspective.
- I'm energized by solving hard problems.
- I'm working backwards from the unmet need.
- I'm a Board Member of the CMT Association.
Leadership Team

Jordan VerPlank, PhD
Chief Scientific Officer (Fractional)
Academic Research Scientist
CMT1A Expert

Wil Chow
Chief Technology Officer (Fractional)
Program Director in 10 Biotechs
7 IND molecules + 2 NDA drugs
Our Scientific Advisors.

Artie Suckow, PhD
Former CEO of DTX Pharma
Board of CMTRF

John Svaren, PhD
U. Wisconsin | Chair CMTA SAB
Co-author Ionis CMT1A paper

Kim Popovits
CEO Genomic Health
Prev. SVP at Genentech

Tom Dubensky, PhD
CEO ImmuneSensor
Board of CMTA

Tim Yu, MD, PhD
Professor Genetics & Genomics
Harvard Medical School

Davy Chiodin
Chief Development Officer
Day One Bio

Venkat Reddy
CSO at General Inception
CEO at Enable Medicine

Phillip Reilly, MD
Co-Founder Luna Genetics
Co-Founder BlueBird Bio

Gregory Reaman, PhD
Prev. FDA Associate Director
Pediatric Oncology

Charlotte Sumner, PhD
Professor of Neuroscience
Johns Hopkins Medical School

Haig Aghajanian, PhD
Co-Founder Capstan Tx
Adj. Prof. U. Pennsylvania

Toby Ferguson, MD, PhD
Chief Medical Officer
Voyager Therapeutics

Steve Scherer, MD, PhD
Professor of Neurology
University of Pennsylvania

Neil Kumar, PhD
Founder & CEO
BridgeBio

Salim Dhanji, PhD
Co-Founder & CEO
ME Therapeutics

Sylvain Gariel
Co-Founder & COO
DNA Script